Therapeutic Control of Aspirin-Exacerbated Respiratory Disease.

Trial Profile

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease.

Phase of Trial: Phase II

Latest Information Update: 24 Apr 2018

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin
  • Indications Asthma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 04 Jan 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top